SE403106B - Forfarande vid framstellning av 14-hydroximorfinanderivat - Google Patents

Forfarande vid framstellning av 14-hydroximorfinanderivat

Info

Publication number
SE403106B
SE403106B SE7306479A SE7306479A SE403106B SE 403106 B SE403106 B SE 403106B SE 7306479 A SE7306479 A SE 7306479A SE 7306479 A SE7306479 A SE 7306479A SE 403106 B SE403106 B SE 403106B
Authority
SE
Sweden
Prior art keywords
hydroximorphinine
derivatives
procedure
preparation
hydroximorphinine derivatives
Prior art date
Application number
SE7306479A
Other languages
English (en)
Swedish (sv)
Inventor
I Monkovic
T T Conway
Original Assignee
Bristol Myers Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Co filed Critical Bristol Myers Co
Publication of SE403106B publication Critical patent/SE403106B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56—Ring systems containing three or more rings
    • C07D209/58—[b]- or [c]-condensed
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/587—Unsaturated compounds containing a keto groups being part of a ring
    • C07C49/753—Unsaturated compounds containing a keto groups being part of a ring containing ether groups, groups, groups, or groups
    • C07C49/755—Unsaturated compounds containing a keto groups being part of a ring containing ether groups, groups, groups, or groups a keto group being part of a condensed ring system with two or three rings, at least one ring being a six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
    • C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
    • C07D221/22—Bridged ring systems
    • C07D221/28—Morphinans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2603/00—Systems containing at least three condensed rings
    • C07C2603/02—Ortho- or ortho- and peri-condensed systems
    • C07C2603/04—Ortho- or ortho- and peri-condensed systems containing three rings
    • C07C2603/22—Ortho- or ortho- and peri-condensed systems containing three rings containing only six-membered rings
    • C07C2603/26—Phenanthrenes; Hydrogenated phenanthrenes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pain & Pain Management (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
SE7306479A 1972-05-10 1973-05-08 Forfarande vid framstellning av 14-hydroximorfinanderivat SE403106B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US25187972A 1972-05-10 1972-05-10

Publications (1)

Publication Number Publication Date
SE403106B true SE403106B (sv) 1978-07-31

Family

ID=22953785

Family Applications (2)

Application Number Title Priority Date Filing Date
SE7306479A SE403106B (sv) 1972-05-10 1973-05-08 Forfarande vid framstellning av 14-hydroximorfinanderivat
SE7604162A SE411042B (sv) 1972-05-10 1976-04-08 Mellanprodukter for framstellning av morinanderivat med analgetisk och/eller narkotikumantagonistverkan

Family Applications After (1)

Application Number Title Priority Date Filing Date
SE7604162A SE411042B (sv) 1972-05-10 1976-04-08 Mellanprodukter for framstellning av morinanderivat med analgetisk och/eller narkotikumantagonistverkan

Country Status (13)

Country Link
US (1) US3775414A (nl)
JP (1) JPS535672B2 (nl)
CA (1) CA989827A (nl)
CH (1) CH590238A5 (nl)
CS (3) CS178425B2 (nl)
DD (1) DD106841A5 (nl)
DK (1) DK138492B (nl)
HU (2) HU168597B (nl)
IL (1) IL42219A (nl)
NL (1) NL155256B (nl)
OA (1) OA04406A (nl)
SE (2) SE403106B (nl)
YU (1) YU36505B (nl)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3910920A (en) * 1973-11-07 1975-10-07 Bristol Myers Co 3,14,17-Substituted-6,7-tetramethylenemorphinans
US3980641A (en) * 1975-07-31 1976-09-14 Bristol-Myers Company Process for the preparation of 14-hydroxymorphinans
US4017497A (en) * 1975-11-18 1977-04-12 Bristol-Myers Company Process for the preparation of 14-hydroxymorphinan derivatives
JPS52136176A (en) * 1976-03-23 1977-11-14 Bristol Myers Co Method of improving 144hydroxymorphinan derivatives
US4139534A (en) * 1977-02-17 1979-02-13 Bristol-Myers Company Process for the preparation of 14-hydroxymorphinan derivatives
US4052389A (en) * 1976-03-23 1977-10-04 Bristol-Myers Company Derivatives of 9,10-dihydroxy-1-(p-alkoxybenzyl)-perhydroisoquinoline oxazine-3-one
US4115389A (en) * 1977-05-02 1978-09-19 Bristol-Myers Company Process of N-demethylating (-)-1-(p-methoxybenzyl)-2-methyl-1,2,3,4,5,6,7,8-octahydroisoquinoline
NO793297L (no) * 1978-10-19 1980-04-22 Mallinckrodt Inc Fremgangsmaate til fremstilling av oksymorfon
US4272540A (en) * 1979-04-24 1981-06-09 Sisa, Incorporated 14-Methoxymorphinan-6-one compounds and therapeutic methods of treating pain and drug dependence with them
NO802139L (no) * 1979-08-09 1981-02-10 Mallinckrodt Inc Utgangsforbindelser for fremstilling av morfinderivater, samt fremgangsmaate til fremstilling av utgangsforbindelsene
US5109136A (en) * 1990-08-09 1992-04-28 Warner-Lambert Company Tetracyclic amines useful as cerebrovascular agents
KR102102513B1 (ko) 2014-10-14 2020-04-20 히사미쓰 세이야꾸 가부시키가이샤 첩부제
WO2017168444A1 (en) * 2016-03-29 2017-10-05 Hikal Limited An improved process for the preparation of butorphanol tartrate
JP6865235B2 (ja) 2016-12-28 2021-04-28 久光製薬株式会社 ブトルファノール含有貼付剤
JP6773897B2 (ja) 2017-04-25 2020-10-21 久光製薬株式会社 貼付剤
US11202764B2 (en) 2017-04-25 2021-12-21 Hisamitsu Pharmaceutical Co., Inc. Patch
CN112592342B (zh) * 2021-01-15 2022-02-22 福安药业集团重庆礼邦药物开发有限公司 一种布托啡诺脱环丁基杂质化合物的制备方法

Also Published As

Publication number Publication date
CS178425B2 (nl) 1977-09-15
US3775414A (en) 1973-11-27
SE7604162L (sv) 1976-04-08
CA989827A (en) 1976-05-25
DD106841A5 (nl) 1974-07-05
HU169023B (nl) 1976-09-28
DK138492C (nl) 1979-02-19
OA04406A (fr) 1980-02-29
CH590238A5 (nl) 1977-07-29
NL155256B (nl) 1977-12-15
CS178446B2 (nl) 1977-09-15
DK138492B (da) 1978-09-18
JPS535672B2 (nl) 1978-03-01
YU119773A (en) 1982-02-25
HU168597B (nl) 1976-06-28
IL42219A0 (en) 1973-07-30
IL42219A (en) 1977-06-30
JPS4961169A (nl) 1974-06-13
SE411042B (sv) 1979-11-26
CS178447B2 (nl) 1977-09-15
NL7306344A (nl) 1973-11-13
YU36505B (en) 1984-02-29

Similar Documents

Publication Publication Date Title
SE407579B (sv) Forfarande for framstellning av n-fosfonometylglycin
SE385885B (sv) Foerfarande foer framstaellning av 4-amino-6-arylpyrimidinderivat
NO140731C (no) Fremgangsmaate for fremstilling av dimetyleter
SE403106B (sv) Forfarande vid framstellning av 14-hydroximorfinanderivat
SE395149B (sv) Forfarande for framstellning av dibenso-tiepinylpiperazinderivat
SE401676B (sv) Forfarande for framstellning av dibensofuranderivat
SE385698B (sv) Forfarande for framstellning av kinolinettiksyraderivat
SE382053B (sv) Forfarande for framstellning av bifenylylalkanoylaminopyridiner
SE420604B (sv) Forfarande for framstellning av oxazolderivat
SE7712151L (sv) Forfarande for framstellning av linkomycinderivat
SE399708B (sv) Forfarande for framstellning av tioxanton-2-karboxylsyraderivat
SE7511680L (sv) Forfarande for framstellning av furanderivat
SE399425B (sv) Forfarande for framstellning av 1-fenoxi-3-aminopropan-2-ol-derivat
SE383151B (sv) Forfarande for framstellning av 1-hydroxi-2-pyridoner
SE380273B (sv) Forfarande for framstellning av tiopyrimidinderivat
SE392615B (sv) Forfarande for framstellning av 2-nitro-5-imidazolaldehydderivat
SE384685B (sv) Forfarande for framstellning av linkomycinderivat
SE380272B (sv) Forfarande for framstellning av n-fosfonmetylglycin
SE393111B (sv) Forfarande for framstellning av d-2-halogen-6-metyl-8-substituerad - ergolin
FI56830B (fi) Foerfarande foer framstaellning av asparaginylgrupper innehaollande biologiskt aktiva polypeptider
SE415355B (sv) Forfarande for framstellning av fosfonotioureider
SE393808B (sv) Forfarande for framstellning av isomaltit
SE7613500L (sv) Forfarande for framstellning av cefemderivat
SE400287B (sv) Forfarande for framstellning av fluorsubstituerade tiaxantenderivat
SE391717B (sv) Forfarande for framstellning av 4-aryl-5-aminoalkyl-4-oxazolin-2-oner